These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35193907)

  • 1. Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol.
    Mutatiri C; Ratsch A; McGrail MR; Venuthurupalli S; Kondalsamy Chennakesavan S
    BMJ Open; 2022 Feb; 12(2):e052790. PubMed ID: 35193907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report.
    Venuthurupalli SK; Healy H; Fassett R; Cameron A; Wang Z; Hoy WE
    Nephrology (Carlton); 2019 Dec; 24(12):1257-1264. PubMed ID: 30663166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia.
    Venuthurupalli SK; Hoy WE; Healy HG; Salisbury A; Fassett RG;
    Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3(Suppl 3):iii139-45. PubMed ID: 23115138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional observation study to investigate the impact of risk-based stratification on care pathways for patients with chronic kidney disease: protocol paper.
    Bhachu HK; Cockwell P; Subramanian A; Nirantharakumar K; Kyte D; Calvert M
    BMJ Open; 2019 Jun; 9(6):e027315. PubMed ID: 31182446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of kidney failure risk equation as a tool to evaluate referrals from primary care to specialist nephrology care.
    Li K; Pirabhahar S; Thomsett M; Turner K; Wainstein M; Ha JT; Katz I
    Intern Med J; 2024 Jul; 54(7):1126-1135. PubMed ID: 38532529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia.
    Venuthurupalli SK; Hoy WE; Healy HG; Cameron A; Fassett RG
    BMC Nephrol; 2017 Jun; 18(1):189. PubMed ID: 28592254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.
    Mahmood U; Healy HG; Kark A; Cameron A; Wang Z; Abeysekera R; Hoy WE
    BMC Nephrol; 2017 Dec; 18(1):372. PubMed ID: 29282014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the kidney failure risk equation to inform clinical care of patients with chronic kidney disease: a mixed-methods systematic review.
    Bhachu HK; Fenton A; Cockwell P; Aiyegbusi O; Kyte D; Calvert M
    BMJ Open; 2022 Jan; 12(1):e055572. PubMed ID: 35042708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.
    Zhang J; Healy HG; Venuthurupalli SK; Tan KS; Wang Z; Cameron A; Hoy WE
    BMC Nephrol; 2019 Sep; 20(1):348. PubMed ID: 31484506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaps in Nephrology Referral Care Utilization in Patients at High-Risk of Progression to Kidney Failure.
    Peter S; Wang M; Chu CD; Tuot DS; Chattopadhyay A; Chen JH
    AMIA Annu Symp Proc; 2022; 2022():866-873. PubMed ID: 37128404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease.
    Arnold JJ; Hayer M; Sharif A; Begaj I; Tabriez M; Bagnall D; Ray D; Hoye C; Nazir M; Dutton M; Fifer L; Kirkham K; Sims D; Townend JN; Gill PS; Dasgupta I; Cockwell P; Ferro CJ
    BMJ Open; 2015 May; 5(4):e006987. PubMed ID: 25941178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cardiovascular events on mortality and progression of renal dysfunction in a Queensland CKD cohort.
    Jeyaruban A; Hoy W; Cameron A; Healy H; Wang Z; Zhang J; Mallett A
    Nephrology (Carlton); 2020 Nov; 25(11):839-844. PubMed ID: 32536031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the kidney failure risk equation in a Portuguese cohort.
    da Silva BM; Charreu J; Duarte I; Outerelo C; Gameiro J
    Nefrologia (Engl Ed); 2023; 43(4):467-473. PubMed ID: 36529658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.
    Winnicki E; McCulloch CE; Mitsnefes MM; Furth SL; Warady BA; Ku E
    JAMA Pediatr; 2018 Feb; 172(2):174-180. PubMed ID: 29255845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol and establishment of a Queensland renal biopsy registry in Australia.
    Burke JP; Aljishi M; Francis L; Hoy W; Divi D; Cherian R; Frazier J; Gobe G; Gois P; Govindarajulu S; Huynh S; Jesudason S; John G; Madhan K; Mallett A; Manickam V; Mutatiri C; Ng SK; Thet Z; Trnka P; Venuthurupalli SK; Ranganathan D
    BMC Nephrol; 2020 Aug; 21(1):320. PubMed ID: 32738876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of patients' and healthcare professionals' perspectives on kidney failure risk and the use of the kidney failure risk equation in MULTIPle lOng-term condItions aNd frailTy (MULTIPOINT) study: a qualitative interview and focus group study protocol.
    Walker H; Sullivan MK; Jani BD; Mark PB; Gallacher KI
    BMJ Open; 2024 Oct; 14(10):e085843. PubMed ID: 39424379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia.
    Mallett A; Patel C; Salisbury A; Wang Z; Healy H; Hoy W
    Orphanet J Rare Dis; 2014 Jun; 9():98. PubMed ID: 24980890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrology consultation and kidney failure in people with stage 4 chronic kidney disease: a population-based cohort study.
    Liu P; Quinn RR; Cortese G; Mahsin M; James MT; Ronksley PE; Quan H; Manns B; Hemmelgarn BR; Tonelli M; Ravani P
    J Nephrol; 2021 Aug; 34(4):1225-1234. PubMed ID: 33211302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.